Brief: Medicamen Biotech Has Filed First ANDA In ECTD Format For Bortezomib For Injection 3.5 Mg/Vial With USFDA
19/07/2023 07:39
July 19 (Reuters) - Medicamen Biotech Ltd MEBI.NS :
* HAS FILED FIRST ANDA IN ECTD FORMAT FOR BORTEZOMIB FOR
INJECTION
3.5 MG/VIAL WITH USFDA
Source text for Eikon: ID:nBSE2CwQ8R
Further company coverage: MEBI.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma